| Bioactivity | BTK-IN-32 (compound C2) is a potent inhibitor of BTK. BTK-IN-32 activates full-length BTK and smaller multidomain BTK fragments instead of the isolated kinase domain[1]. |
| Name | BTK-IN-32 |
| CAS | 1015441-29-8 |
| Formula | C35H35ClN4O3S |
| Molar Mass | 627.20 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kueffer LE, et al. Screening and Characterization of Allosteric Small Molecules Targeting Bruton's Tyrosine Kinase. Biochemistry. 2024 Jan 2;63(1):94-106. |
BTK-IN-32
CAS: 1015441-29-8 F: C35H35ClN4O3S W: 627.20
BTK-IN-32 (compound C2) is a potent inhibitor of BTK. BTK-IN-32 activates full-length BTK and smaller multidomain BTK fr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.